# Prader-Willi Syndrome and Appetite

> **NCT00175305** · PHASE3 · TERMINATED · sponsor: **University of British Columbia** · enrollment: 10 (estimated)

## Conditions studied

- Hyperphagia
- Prader-Willi Syndrome

## Interventions

- **DRUG:** Sandostatin LAR

## Key facts

- **NCT ID:** NCT00175305
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2007-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00175305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00175305, "Prader-Willi Syndrome and Appetite". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00175305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*